Predictors of attitudes toward psychedelics among psychologists in the USA
Jason B. Luoma, Brian Pilecki, Alan K. Davis, Sarah M. Smith
Drugs Education Prevention and Policy September 4, 2022 DOI: 10.1080/09687637.2022.2117022 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Population | Psychologists |
| Topics | Addiction |
| Keywords | Legalization Clinical psychology Psychotherapist |
| Citations | 13 |
| Key findings | Psychologists' attitudes toward psychedelics are associated with gender, age, region, religious affiliation, knowledge, and personal or peer experience, but not with addiction treatment training. |
Abstract
As evidence for psychedelic-assisted therapy accumulates, legalization becomes more likely. As a result, there is an increasing need for psychologists to become educated about psychedelics and their therapeutic effects as they will play an important role in disseminating this treatment. Therefore, understanding psychologists’ current attitudes toward psychedelics is integral in informing dissemination and implementation efforts. In this article, we examined associations between individual difference variables and psychologists’ attitudes toward psychedelics, including age, gender, region, religious affiliation, personal experience with psychedelics, friends’ or loved ones’ experiences with psychedelics, level of training in addiction treatment, and knowledge of psychedelics. Results indicated that participants who were men, lived in West or Northeast regions of the USA, were younger, had greater knowledge of risks and benefits of psychedelics, were religiously unaffiliated, or had direct or indirect (i.e. through peers) experience with psychedelics reported more positive attitudes toward psychedelics. The only variable not associated with more positive attitudes was previous addictions treatment training. These findings suggest that psychologists are not monolithic in their attitudes toward psychedelics. Furthermore, these findings can help inform potential paths for improving attitudes toward psychedelics among psychologists, such as by emphasizing the importance of using case studies in public education efforts.
Comparable studies
Other cross-sectional and survey studies on addiction, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey Online survey respondents | 2020 | Cross-sectional survey | |
| The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations International users of novel psychoactive substances recruited via bluelight.org | 2016 | Cross-sectional online survey | n = 619 |
| User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study Users of hallucinogenic drugs who completed a web-based questionnaire | 2010 | Cross-sectional survey | n = 600 |
| Psychological and neuropsychological assessment of regular hoasca users. Regular hoasca users from a U.S. branch of União do Vegetal and matched non-user controls | 2016 | Cross-sectional study | n = 57 |
| Client and counselor attitudes toward the use of medications for treatment of opioid dependence. Counselors and clients from outpatient, methadone, and residential drug treatment programs | 2007 | Cross-sectional survey | n = 1,459 |
Citations in the library
Cited by 12
- Perceptions and attitudes towards psychedelic-assisted psychotherapy among health professionals, patients, and the public: A systematic review Journal of Psychedelic Studies February 5, 2024
- Differences in attitudes and beliefs about psychedelic-assisted therapy among social workers, psychiatrists, and psychologists in the United States Journal of Psychedelic Studies August 21, 2023
- Avoiding Stigma and Sensationalism in Therapeutic Psilocybin Communications: Considerations for Reaching Older Patients American Journal of Geriatric Psychiatry July 23, 2025
- Pasifika healthcare professionals' perspectives on psychedelic-assisted therapy Journal of Psychedelic Studies June 12, 2025
- Societal perspectives on psychedelics use in clinical context: Development of Concerns and Openness towards Psychedelic Scale (COPS). Dialogues in Clinical Neuroscience March 6, 2025
and 7 more in the library
Cites 18
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
- Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies Journal of Psychopharmacology September 20, 2010
and 13 more in the library